Scholarlink

<p>Leishmaniasis is a devastating neglected tropical disease (NTD) that has affected millions of vulnerable populations globally. Despite incredible pharmaceutical innovations, the existing anti-leishmanial therapy faces several pitfalls, such as drug resistance, toxicity, selectivity, cost concerns, etc. In our efforts to identify new chemical scaffolds, the present investigation scrutinizes the anti-leishmanial potency of the synthesized coumarin-oxime ether derivatives against <i>Leishmania donovani</i> parasites. The primary screening shortlisted six potential molecules (5a, 5d, 5i, 5j, 5k, and 5n) with IC<sub>50</sub> values in the range of 4.97 to 28.72 µM. Among them, two potent hits (5j and 5k) demonstrated a promising cytocompatibility profile coupled with significant effectiveness in clearing the intracellular amastigote burden. Mechanistic insights elucidated that the potent hits (5j and 5k) orchestrated significant cell membrane disruption, escalated cellular ROS, alteration in mitochondrial membrane potential (ΔΨm), ATP depletion, lipid accumulation, and cell cycle disruption culminating in parasitic mortality. Furthermore, computational analysis revealed a dual-targeting strategy wherein the identified molecules (5j and 5k) inhibit the Sterol C-24 methyl transferase (SMT) and Sterol 14-α demethylase (SDM) protein of the ergosterol biosynthesis pathway in <i>Leishmania</i> parasites. Altogether, the present research work highlighted coumarin derivatives as a promising scaffold for developing new, safe, and effective chemotherapeutics to cure leishmaniasis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Coumarin derivatives as new chemotype targeting leishmanial sterol biosynthesis pathway proteins: an integrated in vitro, mechanistic, and in silico evaluation

  • 期刊论文

  • 发表日期：

    2026年4月17日

查看全文
  • Diksha Kumari,
  • Shaik Mahammad Ghouse,
  • Kareena Sinha,
  • Abdul Kalam,
  • Kuljit Singh,
  • Srinivas Nanduri

摘要

Leishmaniasis is a devastating neglected tropical disease (NTD) that has affected millions of vulnerable populations globally. Despite incredible pharmaceutical innovations, the existing anti-leishmanial therapy faces several pitfalls, such as drug resistance, toxicity, selectivity, cost concerns, etc. In our efforts to identify new chemical scaffolds, the present investigation scrutinizes the anti-leishmanial potency of the synthesized coumarin-oxime ether derivatives against Leishmania donovani parasites. The primary screening shortlisted six potential molecules (5a, 5d, 5i, 5j, 5k, and 5n) with IC50 values in the range of 4.97 to 28.72 µM. Among them, two potent hits (5j and 5k) demonstrated a promising cytocompatibility profile coupled with significant effectiveness in clearing the intracellular amastigote burden. Mechanistic insights elucidated that the potent hits (5j and 5k) orchestrated significant cell membrane disruption, escalated cellular ROS, alteration in mitochondrial membrane potential (ΔΨm), ATP depletion, lipid accumulation, and cell cycle disruption culminating in parasitic mortality. Furthermore, computational analysis revealed a dual-targeting strategy wherein the identified molecules (5j and 5k) inhibit the Sterol C-24 methyl transferase (SMT) and Sterol 14-α demethylase (SDM) protein of the ergosterol biosynthesis pathway in Leishmania parasites. Altogether, the present research work highlighted coumarin derivatives as a promising scaffold for developing new, safe, and effective chemotherapeutics to cure leishmaniasis.